Clinical Trials · NCT04997252
An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Zhujiang Hospital
- Enrollment
- 50
- Start date
- Feb 2021
- Locations
- 1 site, China
- Primary endpoint
- rPFS